RICHARD S LINDAHL Insider Trading $EBS Emergent BioSolutions Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD S LINDAHL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD S LINDAHL. RICHARD S LINDAHL is Treasurer in SPRINT Corp ($S) and VP & Treasurer in NEXTEL COMMUNICATIONS INC ($NXTL) and Chief Financial Officer in CEB Inc. ($CEB) and EVP, Chief Financial Officer in Emergent BioSolutions Inc. ($EBS).
RICHARD S LINDAHL in Emergent BioSolutions Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD S LINDAHL: EVP, Chief Financial Officer
Holdings: 36,919 shares
Current Value: $1,083,573
Latest Transaction: May 11 2021
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD S LINDAHL in Emergent BioSolutions Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CEB, EBS, NXTL, S
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 61.62 | 1,054 | 64,947 | 36,919 | 38 K to 36.9 K (-2.78 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 93.49 | 16,043 | 1,499,860 | 16,043 | |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 97.15 | 819 | 79,566 | 37,973 | 38.8 K to 38 K (-2.11 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 93.49 | 1,010 | 94,425 | 38,792 | 39.8 K to 38.8 K (-2.54 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,012 | 0 | 39,802 | 35.8 K to 39.8 K (+11.21 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,011 | 0 | 35,790 | 31.8 K to 35.8 K (+12.62 %) |
| Feb 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 123.45 | 2,522 | 311,341 | 31,779 | 34.3 K to 31.8 K (-7.35 %) |
| Feb 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 2,495 | 0 | 34,301 | 31.8 K to 34.3 K (+7.84 %) |
| May 12 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 79.25 | 728 | 57,694 | 31,806 | 32.5 K to 31.8 K (-2.24 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.44 | 24,414 | 1,499,996 | 44,735 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.44 | 24,414 | 1,499,996 | 44,735 | |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 59.91 | 610 | 36,545 | 32,534 | 33.1 K to 32.5 K (-1.84 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 59.91 | 610 | 36,545 | 32,534 | 33.1 K to 32.5 K (-1.84 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,104 | 0 | 33,144 | 27 K to 33.1 K (+22.57 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,104 | 0 | 33,144 | 27 K to 33.1 K (+22.57 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,103 | 0 | 27,040 | 20.9 K to 27 K (+29.15 %) |
| Feb 27 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 6,103 | 0 | 27,040 | 20.9 K to 27 K (+29.15 %) |
| May 10 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 47.49 | 759 | 36,045 | 20,937 | 21.7 K to 20.9 K (-3.50 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 5,081 | 0 | 21,696 | 16.6 K to 21.7 K (+30.58 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 5,081 | 0 | 16,615 | 11.5 K to 16.6 K (+44.05 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 48.33 | 19,963 | 964,812 | 19,963 | |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,991 | 0 | 11,534 | 6.5 K to 11.5 K (+76.28 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 1,551 | 0 | 6,543 | 5 K to 6.5 K (+31.07 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,992 | 0 | 4,992 | 0 to 5 K |
Page: 1